Thanks to @AfzalValli for turning my £2k ISA Pot into £133k - Current holdings #CTAI#NFX#KDNC#OVB#ROCK. It is great to see people who want to help others succeed
https://t.co/5CmMRSQIa0 https://t.co/4jcDHfpGxv
#CTAI I have been in this since my first purchase at 0.20, I unloaded 10% above 0.40 and re-bought it back in the low 0.30's. Now back to the 100% holding. This latest dip is a massive buying opportunity. You can see the manipulation that took place over the past 3-4 months below, in a step by step breakdown of how it was done on a 4 hour chart
@Catenaiplc
#CTAI@Catenaiplc@alludium
Opening Alludium to the public is a milestone we've been working tirelessly toward since day one. We've spent months refining the platform with our design partners, and we're now ready to put it in the hands of a wider audience. This is the beginning of a new chapter for Alludium," said John Frizelle, Founder & CEO, Alludium.
For Catenai, the launch provides a clearer reference point for the progress of a portfolio company that has been building toward a commercial release.
"Alludium's launch represents the delivery of a commitment we've been building toward since our initial investment. We're proud to see the team reach this milestone and look forward to supporting their continued growth," said John Farthing, CEO, Catenai.
Catenai plans to share more information shortly on the investor presentation and product demonstration.
Investor briefing
Catenai and Alludium plan to host a live investor presentation and product demonstration via the Investor Meet Company platform. Further details, including the date and registration information, are expected to follow.
John Frizelle, Founder & CEO of Alludium, said the move to public access follows months of work with early users.
https://t.co/0ZH1Oj5nOY
#PANR
Multi Billion dollar Alaska LNG Project
Pantheon Resources (PANR) is advancing its Alaska North Slope oil and gas projects—Ahpun and Kodiak—by partnering with the Alaska Gasline Development Corp (AGDC) for the Alaska LNG project. A June 2024 agreement allows PANR to supply natural gas to the proposed pipeline, leveraging low-gas for long-term development.
Key Details on PANR and LNG Projects
Partnership: Pantheon Resources signed a gas supply agreement with AGDC to transport natural gas from its 100% owned Alaskan North Slope acreage.
Strategic Goal: The deal aligns PANR with state interests to advance the multi-billion dollar Alaska LNG project, which aims to transport North Slope gas for export.
Project Status: The project is designed in phases, with the initial phase focusing on the gas pipeline, which helps secure long-term infrastructure for PANR’s resources.
Asset Potential: Netherland, Sewell & Associates estimated significant contingent resources in the Kodiak project (1,208 million barrels of oil and 5,396 billion cubic feet of natural gas).
Resource Advantage: The gas in PANR's fields has low carbon dioxide content, making it suitable for direct, lower-cost transport.
#VAL
Bargain basement - The upside/reward is just too good to miss out on from here 0.30-0.31
ALL FOR £2m MCAP and £1m CASH FUNDED TILL H2 2026
🔷 SP sits near historic lows despite now holding the most extensive and marketable pipeline in Val’s history
🔷 CEO, Mark bought 7% of the company - a rare alignment of insider knowledge and shareholder commitment
🔷 Mark in webinar: “Big pharma are facing a patent cliff by 2030 so seeking to refresh their pipelines”
🔷 Val focus on cancer indications with huge annual markets: triple neg breast ($1.5Bn), prostate ($11.3Bn) & ovarian ($2.5Bn)
🔷 CLX, co-invented by a senior AZN scientist and a leading Kings College prof - serious scientific pedigree
🔷 Discussions with an unnamed major dharma re CLX partnering now ongoing 6+ months, suggests clear progress
🔷 Multiple CLX partnership deals potential with licensing determined by formulation, indication & geographic area.
🔷 Ambrose/401 licence- Val receive 5.7k Ambrose shares with clinical & milestone payments up to £16m & 4 yr target
🔷 Inaphaea are paid upfront for preclinical validation re 401, plus will benefit from any Ambrose funding sourced by Val
🔷 Cash runway confirmed into H2 which excludes R&D tax credits, additional revenue and UK/ international grants
🔷 Revised grant guidelines now prioritise oncology, NAMs & academic/SME collaborations – essentially, Val’s DNA.
🔷 TwinEdge patient avatars allow faster, human-relevant in-silico testing. Mark: “a hot topic for grants”.
🔷 Inaphaea revenues starting to flow with early income from the unique PredictRx platform expected to follow.
🔷 PredictRx uses patient derived tumour cells to reveal the most effective chemotherapy options for that individual.
🔷 Biobank of 476 PDCs /66 indications. Nott’m NHS Trust contract so ongoing supply. £10k per PDC upon commercialisation
🔷 VAL201 – target is to dilute the asset, not Val PLC – a 3rd party takes to clinical for a % share.
🔷 Dominion 3k repurposing project – identified 200 FDA-approved non-oncology drugs, all showing anti-cancer activity
🔷 Mark “particularly excited” about the top 10 “low-hanging fruit” being fast-tracked - all 3k have phase 1 clinical data
🔷 Milestone is to partner primary repurposing candidate this year. Median upfront deal for phase 2 assets now £775m
🔷 Other imminent RNS: new patents, CLX formulation, StingRay, Dundee (“progressing well”)
🔷 Webinar - 2 more evaluations & SPV “with very mature discussions”. SPVs often ring fenced & funded independently
🔷 Advisory Board manned with industry experts focused solely on compounds/activities to be monetise
STRONG INVESTMENTS CASE
#CTAI (.20p) massive news today - the Alludium platform goes live - anticipation of this event took the shares into the mid .60p's in Q4 last year
Current m/cap is just £2.9m !!
Alludium platform launch | Company Announcement | Investegate https://t.co/SOOrVettfa
#CTAI 🔥
These are just few of Alludium major partners
1, AWS -Amazon AWS CEO Matt Garman : Agentic AI has potential to be "the next multi-billion business for AWS
2, Atlassian's suite powers collaboration for millions of teams worldwide. This $50+bn company is the backbone of many AI developers
🌍 (2/2) The #Tirzzit Project in #Morocco targets this deposit style within the Adoudou Formation, with historical drilling and mapping supporting further exploration across the licence area. Learn more about our projects here ⤵️https://t.co/3EpVdk34G7
We're live. Alludium is now in public beta and open to everyone.
Personal AI agents are showing what autonomous AI can do for individuals. Alludium extends that to teams. Build, deploy and collaborate with custom AI agents. No code.
Try it now 👇 https://t.co/Nz75x8Tjwc